These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26240978)

  • 21. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
    Auclair J; Leroux D; Desseigne F; Lasset C; Saurin JC; Joly MO; Pinson S; Xu XL; Montmain G; Ruano E; Navarro C; Puisieux A; Wang Q
    Hum Mutat; 2007 Nov; 28(11):1084-90. PubMed ID: 17557300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
    Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
    Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearer picture of PMS2-associated lynch syndrome is emerging.
    Daniels MS; Lu KH
    J Clin Oncol; 2015 Feb; 33(4):299-300. PubMed ID: 25534383
    [No Abstract]   [Full Text] [Related]  

  • 25. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
    ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
    J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
    Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
    Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
    [No Abstract]   [Full Text] [Related]  

  • 27. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
    Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
    Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PMS2 monoallelic mutation carriers: the known unknown.
    Goodenberger ML; Thomas BC; Riegert-Johnson D; Boland CR; Plon SE; Clendenning M; Win AK; Senter L; Lipkin SM; Stadler ZK; Macrae FA; Lynch HT; Weitzel JN; de la Chapelle A; Syngal S; Lynch P; Parry S; Jenkins MA; Gallinger S; Holter S; Aronson M; Newcomb PA; Burnett T; Le Marchand L; Pichurin P; Hampel H; Terdiman JP; Lu KH; Thibodeau S; Lindor NM
    Genet Med; 2016 Jan; 18(1):13-9. PubMed ID: 25856668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
    Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
    Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
    Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
    Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
    Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
    Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.
    Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Lau YF; Dahiya R; Tanaka Y
    Oncotarget; 2015 Jun; 6(18):16341-51. PubMed ID: 26036629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent advances and future development on Lynch syndrome-associated endometrial cancer].
    Ning Y; Wang Y; Wang YY; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913
    [No Abstract]   [Full Text] [Related]  

  • 37. A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts.
    Sjursen W; Bjørnevoll I; Engebretsen LF; Fjelland K; Halvorsen T; Myrvold HE
    Fam Cancer; 2009; 8(3):179-86. PubMed ID: 19039682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Getting rid of the PMS2 pseudogenes: mission impossible?
    Niessen RC; Kleibeuker JH; Jager PO; Sijmons RH; Hofstra RM
    Hum Mutat; 2007 Apr; 28(4):414; author reply 415. PubMed ID: 17139668
    [No Abstract]   [Full Text] [Related]  

  • 39. PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance.
    van Oers JM; Roa S; Werling U; Liu Y; Genschel J; Hou H; Sellers RS; Modrich P; Scharff MD; Edelmann W
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13384-9. PubMed ID: 20624957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.